Takeda Pharmaceutical (TAK) Tax Rate (2017 - 2026)

Takeda Pharmaceutical's Tax Rate history runs 10 years deep, the most recent figure standing at 23.33% for Q1 2026.

• On a quarterly basis, Tax Rate rose 409.0% year-over-year to 23.33% in Q1 2026; TTM through Mar 2026 was 10.64%, a 1295.0% increase from a year earlier, with the FY2026 full-year figure at 6.86%, down 4510.0% from the prior year.
• Tax Rate retreated to 23.33% in Q1 2026 per TAK's latest filing, from 19.03% in the prior quarter.
• Across five years, Tax Rate topped out at 92.9% in Q4 2023 and bottomed at 41.47% in Q4 2024.
• The 5-year median for Tax Rate is 30.24% (2024), against an average of 16.89%.
• Across the five-year window, Tax Rate surged 8171 bps in 2023 and plunged 13437 bps in 2024, its largest moves.
• Year by year, Tax Rate stood at 11.2% in 2022, then soared by 730 bps to 92.9% in 2023, then plunged by 145 bps to 41.47% in 2024, then soared by 54 bps to 19.03% in 2025, then retreated by 23 bps to 23.33% in 2026.
• Per Business Quant, the three latest TAK Tax Rate figures stand at 23.33% (Q1 2026), 19.03% (Q4 2025), and 30.83% (Q3 2025).